BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32222328)

  • 1. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Lehman CD; Oseni TO; Bahl M
    Acad Radiol; 2020 Oct; 27(10):1394-1399. PubMed ID: 31699638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.
    Kim G; Mikhael PG; Oseni TO; Bahl M
    Eur Radiol; 2020 Nov; 30(11):6089-6098. PubMed ID: 32591884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
    Miceli R; Gao Y; Qian K; Heller SL
    AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
    [No Abstract]   [Full Text] [Related]  

  • 5. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.
    Ko H; Shin J; Lee JE; Nam SJ; Nguyen TL; Hopper JL; Song YM
    BMC Cancer; 2017 Dec; 17(1):821. PubMed ID: 29207971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AI analytics can be used as imaging biomarkers for predicting invasive upgrade of ductal carcinoma in situ.
    Yoon J; Yang J; Lee HS; Kim MJ; Park VY; Rho M; Yoon JH
    Insights Imaging; 2024 Apr; 15(1):100. PubMed ID: 38578585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital Mammography Has Persistently Increased High-Grade and Overall DCIS Detection Without Altering Upgrade Rate.
    Neal CH; Joe AI; Patterson SK; Pujara AC; Helvie MA
    AJR Am J Roentgenol; 2021 Apr; 216(4):912-918. PubMed ID: 33594910
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
    Venkatesh SL; Oseni TO; Bahl M
    Clin Imaging; 2021 May; 73():101-107. PubMed ID: 33360004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
    Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
    Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
    Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
    J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging and pathologic features of non-calcified ductal carcinoma in situ: can sonography predict upgrade?
    Komarla R; Gilliland L; Piraner M; Seidel R; Clifford K; Kunjummen J
    Br J Radiol; 2022 Feb; 95(1130):20211013. PubMed ID: 34870448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upgrade Rate of Ductal Carcinoma In Situ to Invasive Carcinoma and the Clinicopathological Factors Predicting the Upgrade Following a Mastectomy: A Retrospective Study.
    Al-Ishaq Z; Hajiesmaeili H; Rahman E; Khosla M; Sircar T
    Cureus; 2023 Mar; 15(3):e35735. PubMed ID: 37016659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Architectural Distortion on Digital Breast Tomosynthesis With Nonmalignant Pathology at Biopsy.
    Villa-Camacho JC; Bahl M
    AJR Am J Roentgenol; 2022 Jul; 219(1):46-54. PubMed ID: 35107312
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
    Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
    Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.